This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these messages)
|
Company type | Private [1] |
---|---|
Industry | Conglomerate |
Founded | 13 January 2006 |
Founder | |
Headquarters | , India |
Area served |
|
Key people | Balkrishna (chairperson, managing director & CEO) |
Products | |
Revenue | ₹9,872 crore (US$1.2 billion) (2021) [3] |
₹485 crore (US$58 million) (2021) [3] | |
Owner | Balkrishna (94%) |
Number of employees | 6,395 (November 2023) [4] |
Subsidiaries |
|
Website | patanjaliayurved |
Patanjali Ayurved is an Indian multinational conglomerate holding company, based in Haridwar. It was founded by Ramdev and Balkrishna in 2006. [5] Its office is in Delhi, with manufacturing units and headquarters in the industrial area of Haridwar. [6] The company manufactures cosmetics, ayurvedic medicine, personal care and food products. [7] The CEO of the company, with a 94-percent share hold, is Balkrishna. Ramdev represents the company and makes strategic decisions. [8] [9] [10] The company has faced various controversies over its misleading promotions and false claims for COVID-19 treatment. [11]
Ramdev and Balkrishna established Patanjali Ayurved in 2006. [5] [12] [13] Balkrishna owns 94 percent of the company, and the remainder is dispersed among other individuals. [9] In May 2021, Balkrishna had a net worth of US$2.3 billion. [14]
According to CLSA and HSBC, Patanjali was one of the fastest-growing FMCG companies in India in 2016. It was valued at ₹3,000 crore (equivalent to ₹43 billionorUS$520 million in 2023). [15] [16] [17] Patanjali estimated its annual turnover for the 2016–17 fiscal year at ₹10,216 crore (US$1.2 billion). [18] According to a report by India Infoline (IIFL), at least 13 listed companies would be affected by Patanjali's success; they included Hindustan Unilever, Colgate, Dabur, ITC, and Godrej Consumer Products. [17]
This section needs additional citations for verification .(September 2024) |
Year | Revenue in crores |
---|---|
2010–11 | ₹1000 |
2011–12 | ₹300 |
2012–13 | ₹841 |
2013–14 | ₹1,184 |
2014–15 | ₹2,006 |
2015–16 | ₹8,000 |
2016–17 | ₹10,526 [19] |
2017–18 | ₹9,500 [20] |
2018–19 | ₹8,330 [21] |
2019–20 | ₹30,000 |
Future Group, which has joined with Patanjali, sells about ₹30 crore (US$3.6 million) worth of Patanjali products every month. [22] [23] [24]
Patanjali Food and Herbal Park in Haridwar is the company's main production facility. With a production capacity of ₹35,000 crore (equivalent to ₹470 billionorUS$5.6 billion in 2023), it is expanding to a capacity of ₹60,000 crore (equivalent to ₹860 billionorUS$10 billion in 2023) through new production units in Noida, Nagpur, and Indore. [20] [25] [26]
In 2016, the Patanjali Food and Herbal Park received 35 full-time, armed Central Industrial Security Force (CISF) commandos. [27] [28] [29] The park will be the eighth private institute in India to be guarded by paramilitary CISF forces. [29]
Ramdev has had 100 cases filed against him by the Government of Uttarakhand for a number of offences. [30] Of these, 81 cases against Patanjali Yogpeeth and its sister concerns in Haridwar were registered for violations of the Zamindari Abolition and Land Reforms (ZALR) Act and the Indian Stamps Act. [31]
The company has been accused of misleading advertising [32] [33] about its products and flimsy testing before being marketed. [34] Between April 2015 and July 2016, 33 complaints were received against 21 misleading advertisements; seventeen violated ASCI standards. [35] In September 2017, the Delhi High Court ordered the company to stop airing an advertisement for its brand of chyavanprash which disparaged a competitor's. [36] Company products, such as amla juice [37] [38] and ayurvedic medicines [39] have been banned for poor quality. [38] [40]
Patanjali has been cited for its working conditions; Ramdev and Balkrishna are treated as gurus whose feet must be touched each time they enter an area. Workers are paid ₹6,000 (US$72) per month, working 12-hour shifts, six days a week. [38] [41] They are also discouraged from asking for a raise, with the rationale that working at the factory is considered "seva" (voluntary service) to the cause and is a payment in itself. [41] [42] [43] On 22 May 2021, the Indian Medical Association (IMA) in Uttarakhand sent a defamation notice of ₹1,000 crore (equivalent to ₹11 billionorUS$130 million in 2023) after remarks by Ramdev about doctors who practise evidence-based medicine. [44] [45]
One of the products manufactured by Ramdev's Divya pharmacy and sold by the Patanjali Pharmacy chain was Divya Putrajeevak Seed, described in its catalog as a natural herb which (according to the company) could treat infertility. However, doctors pointed out the misleading name of the drug: the word "putrajeevak" (lit. transl. "son's life" ). Some Patanjali Pharmacy stores sold the drug with the claim that it would ensure the birth of a boy, reportedly leading to an increase in sales. [46]
The issue was raised in the Indian Parliament in July 2015 by opposition members who accused Ramdev of "peddling a product which promised delivery of male children." The Ministry of AYUSH (which oversees the sale of alternative medicines) defended the product's name, saying that it was named after a herb. [47]
In 2016, the Uttarakhand health department said that the drug violated the Pre-Conception and Pre-Natal Diagnostic Techniques Act, 1994. [48] The Maharashtra government ordered a probe of whether the drug had violated laws in 2018, and Congress leaders in the state demanded a ban on the drug. [49]
In January 2018, villages in Haridwar district complained that Patanjali's Padarth factory was polluting a Ganges channel and other local rain-fed bodies of water with surface runoff; chemicals released by the factory reportedly killed several animals in the area. The local government took no action on the factory due to Ramdev's influence, and residents of 40 villages threatened agitation. [50] The Uttarakhand Environment Conservation and Pollution Control Board ordered a clean-up of the waste flowing through the area. In the past, the board had notified Padarth about its release of untreated industrial effluent into local bodies of water. Patanjali's general manager denied the allegations, saying that the company followed established protocols. [50]
The Ministry of Defence canteen stores department (CSD) suspended Patanjali Ayurved's amla juice after receiving an adverse state laboratory test report on the product; the central food laboratory found the juice unfit for consumption. The CSD asked its depots to make debit notes for their existing stock, so the product could be returned. [37] [38] [40] [51]
Patanjali introduced its instant noodles on 15 November 2015. [52] [53] [54] The Food Safety and Standards Authority of India notified the company that neither Patanjali nor Aayush, the brand names for which Patanjali obtained licenses, received approval for the manufacture of instant noodles. [55] [56] [57] [58] In Rajasthan, mustard oil sold by Patanjali was found substandard by the FSSAI's Alwar laboratory. [59]
Ministry of AYUSH has advised certain states to take necessary action against Baba Ramdev's Patanjali Ayurved for illegally promoting products that claimed to cure diabetes, heart and liver diseases. The Ministry has specifically sought action against the advertisements of three Patanjali products — Lipidom, Livogrit and Livamrit. [60] [61] [62]
Patanjali Ayurved announced a drug named Coronil for COVID-19 treatment in June 2020, with Ramdev claiming that it cured the disease. [63] [64] [11] There was no clinical data to prove that the new drug was effective or even safe; this prompted a social-media backlash which questioned the role of the Ministry of AYUSH. [65] Within hours of Coronil's introduction, the ministry issued a statement denying authorisation for the new drug and asking the company to stop selling (and advertising) it until the trial results were examined by medical authorities. [66] [67] [68] An official from the ayurved department of the government of Uttarakhand said that the approval application for Coronil had not mentioned COVID-19. [69]
Laboratory tests showed that the drug did not contain any ingredients which could treat or prevent coronavirus infections. The Indian government allowed Patanjali Ayurved to market Coronil as an immunity booster (not a cure), [11] but the Government of Maharashtra has banned the sale of Coronil in the state. First information reports were filed in Bihar and Rajasthan against Ramdev, Balkrishna and others, accusing them of dishonesty and selling fake medicines. [70] [71] Patanjali responded to the accusations, saying that they did not violate any procedures before the drug was launched. [72] A Madras High Court judge fined the company ₹1,000,000 (US$12,000) for making false claims about the drug, and Patanjali withdrew its claim that Coronil could cure COVID-19. The UK drug regulator threatened action if unauthorized products were sold in the UK. [11]
The government of Maharashtra banned Coronil in the state in June 2020, with home minister Anil Deshmukh threatening the company with legal action if they did not observe the ban. [73] The Madras High Court also barred Patanjali Ayurved from using the name "Coronil". [74] [75] The court's order came while it heard a suit filed by a Chennai-based firm which said that it had owned the trademark "Coronil" since 1993. Making an earlier interim injunction against Patanjali absolute, Madras High Court Justice C. V. Karthikeyan also imposed the fine on the company. [76] [77] In his ruling, the judge observed that Patanjali had been "chasing further profits by exploiting the fear and panic among the general public by projecting a cure for the coronavirus when their 'Coronil Tablet' is not a cure". [78] [74] [79] Nepal and Bhutan halted the distribution of donated Coronil after orders from their governments to disclose that it was not a medicine to cure COVID-19. [80] [81]
In February 2021, The Indian Express , The Times of India , The Hindu and Livemint reported Patanjali Ayurved's claim that Coronil had been approved by the Ministry of AYUSH and certified by the World Health Organization. The reports indicated that Ramdev had released studies showing that Coronil was effective against COVID-19 at a press conference attended by Union Health Minister Harsh Vardhan and transport minister Nitin Gadkari. [82] [83] [84] [85] In a News Nation interview, Ramdev accused doctors of "allopathic terrorism" for doubting Coronil's effectiveness. [86] The claim was endorsed by Bharatiya Janata Party spokesperson Sanju Verma, who called it "... a huge endorsement for Ayurveda India's homegrown StartUp ecosystem that has flourished under @narendramodi govt." [86] Verma described the approvals granted to Coronil as a "slap in the face" to the BJP's opposition. [87]
On 22 February, the WHO said that it had not "... reviewed or certified the effectiveness of any traditional medicine for the treatment #Covid19." [88] Several news and fact-checking outlets, including The Wire , Alt News , BBC News and The Economic Times , ran fact-checking articles debunking Ramdev and Patanjali's claims; Coronil had received an export license, and had not received any approval regarding its effectiveness as a treatment against COVID-19. [89] [90] [86] [91] Patanjali Ayurveda CEO Balkrishna admitted on Twitter that the approval for Coronil had not come from the WHO or the Ministry of AYUSH (as they had claimed), but had been granted by the Drugs Controller General of India for export –not as a certification of effectiveness. [86] [89]
In August 2022, Newslaundry published a report alleging that Patanjali took control of Dalits' lands for cow shelter and herb farms in Teliwala village, Uttarkhand through force and circumvention of laws, making people there landless. [92] With their land in control of Patanjali, Dalits have no choice other than working for the company or migrating elsewhere for finding employment.
In May 2023, a Delhi-based law firm issued a legal notice to Patanjali Ayurved accusing the company of using 'cuttlefish bones' in dental care product, branding non-veg product as vegetarian in violation of the law. [93]
In August 2022, the Indian Medical Association filed a petition accusing Patanjali of disparaging allopathy to promote its drugs, alleging a violation of both the Drugs and Other Magical Remedies Act, 1954 (DOMA) and the Consumer Protection Act, 2019 (CPA). Subsequently, in November 2023, the Supreme Court cautioned Patanjali against misleading advertisements and threatened a fine of Rs 1 crore per product for any deceptive claims. Despite assurances following the warning, Patanjali continued publishing misleading ads. [94] [95]
In February 2024, the Supreme Court imposed a temporary ban on the company's advertisements and issued a contempt notice to Patanjali and its managing director Balkrishna. In response, the Supreme Court directed Patanjali to publish apologies in newspapers. Initially, Patanjali issued small apologies, which were deemed insufficient by the court. Consequently, Patanjali released larger apologies in newspapers as instructed by the court. Additionally, the Uttarakhand Licensing Authority revoked licenses for 14 Patanjali products after facing scrutiny from the Supreme Court over regulatory inaction. [96] [97]
In August 2024, the Supreme Court closed contempt proceedings against Patanjali Ayurved co-founders Baba Ramdev and Acharya Balkrishna, and their company in the misleading advertisements case, accepting the apology tendered by the parties after they took steps to rectify their mistake. The top court, however, warned that both Ramdev and Balkrishna should comply with all future orders and not repeat their past conduct. [98] [99]
Patanjali Ayurved produces cosmetics and personal-care, ayurvedic and food products. [100] [101] [102] The company opened Patanjali Paridhan, a clothing store in Delhi, in November 2018. [103]
In May 2016, the company had nearly 4,700 retail outlets. [101] [104] Patanjali also sells its products online, and is planning to open outlets at railway stations and airports. [105] The company joined Pittie Group and Kishore Biyani's Future Group on 9 October 2015, [101] making its products available in Future Group outlets. [106] [107] [108] Patanjali Ayurveda products are also available at Reliance Retail, Hyper City and Star Bazaar. [101] [109] [110] [111] [112] The company had a target revenue of ₹10,000 crore (US$1.2 billion) revenue in 2016–17, after sales increased by 150 percent in the previous financial year to ₹5,000 crore (US$600 million). [113]
Patanjali Ayurved's advertisement and sales promotion expenses in FY24 rose by 145.46% compared to FY23, increasing from Rs 173.13 crore to Rs 424.7 crore [114]
In December 2019, Patanjali reportedly acquired bankrupt Ruchi Soya Industries for ₹4,350 crore (US$520 million). [115]
Dabur Ltd is an Indian multinational consumer goods company, founded by S. K. Burman and headquartered in Ghaziabad. It manufactures Ayurvedic products and fast-moving consumer goods. Dabur derives around 60% of its revenue from the consumer care business, 11% from the food business and remaining from the international business unit.
Ramdev, known also by the prefix Baba, is an Indian yoga guru, businessman and brand ambassador for Patanjali Ayurved. He is primarily known for being a proponent of yoga and ayurveda in India. Ramdev has been organizing and conducting large yoga camps since 2002 and broadcasting his yoga classes on various TV channels. He co-founded Patanjali Ayurved and Patanjali Yogpeeth with his colleague Balkrishna in 2006. Ramdev has received criticism over his comments related to modern medicine, yoga, and ayurveda.
The Ministry of Ayush, a ministry of the Government of India, is responsible for developing education, research and propagation of traditional medicine and alternative medicine systems in India. Ayush is a name devised from the names of the alternative healthcare systems covered by the ministry: ayurveda, yoga and naturopathy, Unani, Siddha, Sowa Rigpa, and homeopathy.
Patanjali Yogpeeth is a yoga institute located in Haridwar, Uttarakhand, India. Founded in 2006 and named after the Rishi Patanjali, the purpose of the institute is to practice, research, and develop yoga and ayurveda. The institute is the flagship project of the yoga teacher and entrepreneur Ramdev.
Emami Group is an Indian multinational conglomerate headquartered in Kolkata. The company caters to a number of niche categories in the personal care and healthcare segments.
Reliance Retail is an Indian retail company and a subsidiary of Reliance Industries. Founded in 2006, it is the largest retailer in India in terms of revenue. Its retail outlets offer foods, groceries, apparel, footwear, toys, home improvement products, electronic goods, and farm implements and inputs. As of 2023, it has over 245,000 employees at 18,000 store locations in 7,000 towns.
Rajiv Dixit was an Indian social activist who founded the Azadi Bachao Andolan.
Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients (APIs). Ipca sells these APIs and their intermediates globally. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules.
Patanjali Foods, formerly known as Ruchi Soya Industries Ltd, is an Indian multinational fast-moving consumer goods company specialized in the food industry, part of the Patanjali Ayurved. It is headquartered in Indore, India.
Tata Consumer Products Limited is an Indian fast-moving consumer goods company and a part of the Tata Group. Its registered office is located in Kolkata while its corporate headquarters is in Mumbai. It is the world's second-largest manufacturer and distributor of tea and a major producer of coffee.
Devgn Films, formerly known as Ajay Devgn FFilms, is an Indian film production and distribution company established by actor Ajay Devgn and his father Veeru Devgn in 1999. Based in Mumbai, it mainly produces and distributes Hindi films. In 2000, Devgn Films released its first film, Raju Chacha. The film starred Devgn and Kajol. Raju Chacha received mixed reviews but grossed ₹82.5 million at the box office. In 2015, Devgn started a visual effects company, NY VFXWAALA.
Harsh Vardhan is a former Indian politician and otorhinolaryngologist. He had served as the Minister of Health and Family Welfare, Minister of Science and Technology and Minister of Earth Sciences in the BJP-led NDA government of Prime Minister Narendra Modi from 30 May 2019 to 7 July 2021. He represents Chandni Chowk in Delhi as a Member of Parliament in the 17th Lok Sabha. He was elected to the office of chairperson of the executive board of the World Health Organization from 22 May 2020. Vardhan has been prominent in the Indian government's response to the COVID-19 pandemic. He later resigned from his cabinet post ahead of the cabinet reshuffle in July 2021.
FSN E-Commerce Ventures Ltd, d/b/a Nykaa, is an Indian retail company, headquartered in Mumbai. It sells beauty, wellness and fashion products through its website, mobile app and over 100 physical stores. In 2020, it became the first Indian unicorn startup headed by a woman.
University of Patanjali is an Indian private research university, with its main campus in Haridwar, Uttarakhand. It was established in 2006 after the Legislative Assembly of Uttarakhand passed the University of Patanjali Act, 2006. It was founded by Baba Ramdev and Acharya Balkrishna.
Patanjali was an ancient Indian author, mystic and philosopher.
Fatah Ka Fatwa was an Indian discussion show, hosted by Tarek Fatah on Hindi news channel Zee News. The 17-episode show focuses on issues relevant to Islam, such wearing the Hijab, the concept of a Kafir, Nikah mut‘ah, Nikah Halala, Islamic banking and finance, Child marriage etc. The series tries to explain various facets of the Quran as well as other theological nuggets of Islam. Asian Paints was initially the sponsor of the programme but company had to withdraw its support after an online petition was started calling Indian Muslims to boycott the brand, but later yoga guru Baba Ramdev’s Patanjali Ayurved Ltd. stepped forward to offer the crucial sponsor support to Zee News and became its sponsor. Season 1 of the show ended on 6 May 2017.
Balkrishna is an Indian billionaire businessman and chairman of the consumer goods company Patanjali Ayurved. He was reported by Forbes to have a net worth of US$2.3 billion as of May 2021. According to Ashish Kumar of Arya Samaj, Balkrishna has successfully established and managed a global business without a formal education.
Swami Ramdev - Ek Sangharsh is an Indian biopic television series based on the life on Swami Ramdev. It is produced by Ajay Devgn FFilm Productions and Watergate Productions. It premiered on 12 February 2018 on Discovery Jeet. The show launched on Netflix with the title Swami Baba Ramdev: The Untold Story.
Institute of Teaching and Research in Ayurveda (ITRA) Jamnagar, Gujarat, India which was founded in 1967. It has a joint campus with, an Institute of National Importance, established in 2020.
Honorable Thiru. C. V. Karthikeyan is a sitting Judge of the Madras High Court. He is one of the Members of the Board of Governors of the Tamil Nadu State Judicial Academy.
{{cite web}}
: |last=
has generic name (help)